Leptomeningeal Neoplasm — Trials

Leptomeningeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

32 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03501979	Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD	terminated	Phase 2	17	University of Alabama at BirminghamOTHER	1	Aug 29, 2025	clinicaltrials
NCT05414123	A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide(FORESEE)	terminated	—	40	Biocept, Inc.INDUSTRY	1	Oct 16, 2023	clinicaltrials
NCT03711422	Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC	terminated	Phase 1	2	National Cancer Centre, SingaporeOTHER	1	Jun 14, 2022	clinicaltrials
NCT02967380	Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

Data updated 22 days agoSource updated Aug 29, 2025source: clinicaltrials